Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-25-001164

Options or other derivatives

  • Director acquired 31,613 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
McLoughlin Margaret Director 2025-01-02 Grant or award · Director Stock Option (right to buy) +31,613 31,613 D: show line 1 in the form
Loading xslF345X05/form4-01092025_120123.xml…